相关实验视频
Updated: Jul 16, 2025

08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
10.9K
在帕金森病的非侵入性神经调节:从动物模型的见解
Katherine Muksuris1, David M Scarisbrick2,3, James J Mahoney2,3
1Department of Psychology, West Virginia University, Morgantown, WV 26506, USA.
Journal of clinical medicine
|September 9, 2023
概括
像TMS和tDCS这样的非侵入性神经调节技术在帕金森病 (PD) 治疗中表现有前途. 动物研究正在探索这些新型PD治疗方法背后的机制.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 目前的帕金森病 (PD) 治疗主要涉及药物治疗和深度大脑刺激.
- 这些已建立的干预措施提供了症状缓解,但不能阻止疾病的进展.
- 新兴研究探索非侵入性神经调节作为PD的潜在治疗策略.
研究的目的:
- 审查有关帕金森病非侵入性神经调节技术的动物文献.
- 在PD模型中阐明这些非侵入性方法的潜在治疗机制.
- 评估PD新型治疗方法的疗效和基础科学.
主要方法:
- 快速审查研究PD非侵入性神经调节的动物研究.
- 包括跨磁刺激 (TMS),跨直流刺激 (tDCS),电疗法 (ECT) 和聚焦超声波 (FUS).
- 对发现的分析,以了解治疗机制.
主要成果:
- 像TMS,tDCS,ECT和FUS这样的非侵入性技术正在PD的动物模型中进行研究.
- 这些方法显示了PD治疗效果的潜力.
- 动物研究为PD中神经调节的机制基础提供了洞察力.
结论:
- 非侵入性神经调节是帕金森病治疗发展的前沿.
- 对动物模型的进一步研究对于理解和优化这些疗法至关重要.
- 阐明机制可以指导这些技术转化为PD患者的临床实践.
相关概念视频
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592

